Cynthia A. Sanoski, PharmD

Contact Dr. Sanoski

130 South 9th Street
Suite 1540
Philadelphia, PA 19107

(215) 503-6397
(215) 503-9052 fax

Education
BS, Pharmacy, Duquesne University, College of Pharmacy, Pittsburgh, PA

PharmD, Ohio State University, College of Pharmacy, Columbus, OH

Fellowship
Post-Doctoral Cardiovascular Pharmacotherapy, University of Illinois at Chicago, College of Pharmacy, Chicago, IL

University Appointment
Chair, Associate Professor of Pharmacy Practice

Professional Organizations
American College of Clinical Pharmacy
American Society of Health-System Pharmacists
American Association of Colleges of Pharmacy
Mid-Atlantic College of Clinical Pharmacy
American Heart Association
Pennsylvania Pharmacists Association
American Pharmacists Association

Publications

Most recent Peer-reviewed Publications

1. Medication adherence and persistence in hypertension management
2. Professional technical standards in colleges and schools of pharmacy
3. Understanding atrial fibrillation and new therapeutic advances to improve its management: Introduction
4. Overview of electrocardiographic findings and clinical presentation of common cardiac arrhythmias
5. Prevalence, pathogenesis, and impact of atrial fibrillation
6. Clinical, economic, and quality of life impact of atrial fibrillation
7. Journal of Managed Care Pharmacy: Introduction
8. Atrial fibrillation and managed care: current approaches and future directions for long-term therapy. Introduction.
9. Aliskiren: An oral direct renin inhibitor for the treatment of hypertension
10. Role of angiotensin- converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias
11. Pharmacotherapy considerations in advanced cardiac life support
12. American College of Clinical Pharmacy's vision of the future: Postgraduate pharmacy residency training as a prerequisite for direct patient care practice
13. Tecadenoson: A novel, selective A1 adenosine receptor agonist
14. Rate vs rhythm control in patients with atrial fibrillation: A meta-analysis
15. Key articles and guidelines in pharmacotherapeutic management of arrhythmias.
16. Management of dyslipidemia: An update
17. Multicenter treat-to-target cost-effectiveness evaluation of HMG-CoA reductase inhibitor monotherapy
18. Introduction: Cardiovascular pharmacotherapy
19. ACLS guidelines 2000: Focus on what's "new" in the pulseless ventricular tachycardia/ventricular fibrillation algorithm
20. Clinical observations with the amiodarone/warfarin interaction: Dosing relationships with long-term therapy

View All Publications